Position: Clinician Scientist as leader of the Junior Clinical Cooperation Unit (CCU) "Translational Molecular Imaging in Oncologic Therapy Monitoring"

Department: Management Board

Code number: 2022-0220

The German Cancer Research Center is the largest biomedical research institution in Germany. With more than 3,000 employees, we operate an extensive scientific program in the field of cancer research.

Our mission is to unravel the causes and mechanisms underlying cancer development and progression and, based on innovative research, develop novel strategies for the diagnosis, early detection, prevention and treatment of cancer. Located on the biomedical campus in Heidelberg, the DKFZ is embedded in a highly attractive scientific environment offering a broad spectrum of opportunities for collaborations. Moreover, we provide excellent research conditions, an international and collegial research environment and access to state-of-the-art core facilities.

The University Medical Center Mannheim stands for quality-assured, university-based maximum care and is one of the largest medical institutions and research centers in the region. With the Mannheim Medical Faculty, Heidelberg University and the Mannheim University Medical Center, two strong partners are united. Every year, around 52,000 inpatients and day patients as well as 212,000 outpatients are treated with a wide range of state-of-the-art diagnostic and therapeutic procedures. In 30 specialized clinics and institutes, 5,000 employees are equally committed to patient care, research and teaching.

The "DKFZ Hector Cancer Institute at the University Medical Center and Medical Faculty Mannheim" was established in 2019 as a long-term partnership between the University Medical Center Mannheim, the Medical Faculty Mannheim,Heidelberg University and DKFZ, and is generously supported by the Hector Foundation II. A major goal of the newly established "DKFZ Hector Cancer Institute at the University Medical Center and Medical Faculty Mannheim" is to improve personalized oncology and to bring innovative research results more rapidly into clinical application in the form of clinical trials.

The clinical-oriented research unit will contribute to the promotion of early career scientists in the field of molecular imaging with a focus on positron emission tomography (PET) and monitoring of oncological therapies. To this end, the Clinician Scientist will perform his/her translational cancer research (50%) at the DKFZ and his/her clinical activities (50%) at the Department of Radiology and Nuclear Medicine, University Medical Center Mannheim and Mannheim Medical Faculty, Heidelberg University.

Job description:

We are seeking a highly qualified and exceptionally motivated Clinician Scientist as leader of an independent Junior Clinical Cooperation Unit (CCU).

Aim is to advance monitoring of therapeutic response and predicting therapeutic outcome in oncology based on methodological progress in radiochemistry, radiopharmacy as well as PET imaging technology. The leader of the Junior CCU will work closely with an interdisciplinary team of radiochemists, radiopharmacists, PET physicists, molecular imaging and nuclear medicine specialists as well as radiologist. Focus should be on translational imaging research exploiting the full range of basic and clinical research environment of the DKFZ and the University Hospital Mannheim. As part of this comprehensive concept, the partner institutions offer a GMP compliant radiopharmacy laboratory, strong support by world leading radiochemists as well as cutting edge technology such as long axial field of view (LAFOV) 4D PET and PET/MRI imaging technology. Imaging will be performed in collaboration of the Departments of Radiology and Nuclear Medicine at the University Hospital Mannheim and Radiology at the DKFZ. Close collaboration with the study outpatient clinic of the „DKFZ Hector Cancer Institute at the University Medical Center and Medical Faculty Mannheim“ is expected to recruit patients with specific oncologic diseases eligible for clinical trials with innovative PET tracers.


Eligible applicants are Clinician Scientists (physician in residency or completed residency) that hold a doctoral degree and the license to practice medicine. Applicants must have clinical training in the field of molecular imaging/nuclear medicine either as a senior resident or already board-certified young fellow with a strong interest in oncologic imaging.


  • Clinical training in nuclear medicine on a senior resident level (at least “Fachkunde Strahlenschutz” in diagnostic Nuclear Medicine or equivalent European board certification)     
  • Strong knowledge in PET methodology, radiotracers and basic knowledge in GMP laboratory work
  • Post-doctoral scientific training and ability to conduct independent scientific work with emphasis in cutting edge PET applications as well as molecular imaging technology         
  • Participation or completion of a Clinician Scientist program would be advantageous
  • Proven record of publications in peer-reviewed international journals as an exposed author
  • Ability to successfully raise extramural funding
  • Team spirit and communication skills
  • Professional networking in the clinical and scientific field
  • Very good knowledge of German and English
  • High motivation and ability to work independently

To apply, please submit a cover letter, curriculum vitae, list of publications, summary of past research and future plans (max. 5 pages) and names and addresses of two to three references using our online application portal (www.dkfz.de/jobs). Applications will be preselected and short-listed candidates will be invited to present and discuss their research and future plans.

We offer:

  • Interesting, versatile workplace
  • International, attractive working environment
  • Campus with modern state-of-the-art infrastructure
  • Salary according to TV-L including social benefits
  • Possibility to work part-time
  • Flexible working hours
  • Comprehensive further training program

Important notice:

The DKFZ is subject to the regulations of the Infection Protection Act (IfSG). As a consequence, only persons who present proof of immunity against measles as well as against COVID-19 may work at the DKFZ.

Earliest Possible Start Date: as soon as possible

Duration: The position is limited to 5 years with the possibility of prolongation.

The position can in principle be part-time.

Application Deadline: 14.07.2022


Prof. Dr. med. Michael Baumann
Phone +49 (0)6221/42-2850

Please note that we do not accept applications submitted via email.

The DKFZ is committed to increase the proportion of women in all areas and positions in which women are underrepresented. Qualified female applicants are therefore particularly encouraged to apply.

Among candidates of equal aptitude and qualifications, a person with disabilities will be given preference.

To apply for a position please use our online application portal (https://www.dkfz.de/en/stellenangebote/index.php).

We ask for your understanding that we cannot return application documents that are sent to us by post (Deutsches Krebsforschungszentrum, Personalabteilung, Im Neuenheimer Feld 280, 69120 Heidelberg) and that we do not accept applications submitted via email. We apologize for any inconvenience this may cause.